2-氨基-6,8-二羟基嘌呤，CAS 登记号 5614-64-2，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 2-氨基-6,8-二羟基嘌呤 的 CAS 号：5614-64-2，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
2-Amino-6,8-dihydroxypurine · CAS 5614-64-2 · C5H5N5O2. UNII V5WDN6HY4L.
| CAS Registry Number | 5614-64-2 |
|---|---|
| PubChem CID | 135420630 |
| Molecular formula | C5H5N5O2 |
| IUPAC name | 2-amino-7,9-dihydro-1H-purine-6,8-dione |
| UNII (FDA) | V5WDN6HY4L |
| Molecular Weight | 167.13 |
|---|---|
| XLogP3 | -2.2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 167.04432442 |
| Monoisotopic Mass | 167.04432442 |
| Topological Polar Surface Area | 109 |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Reported hazard statements | H315 (100%), H319 (100%), H335 (100%) |
|---|
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
8-Hydroxyguanine; 5614-64-2; 2-Amino-6,8-dihydroxypurine; 7,8-dihydro-8-oxoguanine; 2-amino-7,9-dihydro-1H-purine-6,8-dione; 2-Aminopurine-6,8-diol; 8-oxo-7,8-dihydroguanine; 1H-Purine-6,8-dione, 2-amino-7,9-dihydro-; V5WDN6HY4L; DTXSID10204673; NSC-22720; CHEBI:52617; 2-amino-6,7,8,9-tetrahydro-1H-purine-6,8-dione; 8-oxoG nucleobase; 8-Oxo-Gua; RefChem:548156
CAS 5614-64-2; molecular formula C5H5N5O2; molecular weight — g/mol.
8-Hydroxyguanine, 5614-64-2, 2-Amino-6,8-dihydroxypurine, 7,8-dihydro-8-oxoguanine, 2-amino-7,9-dihydro-1H-purine-6,8-dione, 2-Aminopurine-6,8-diol.
Hazard statements reported: H315, H319, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.